Overview

Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To identify efficacy and safety of Telmisartan/Rosuvastatin co-administration in hyperlipidemia control in hypertensive patients with hyperlipidemia compared to each monotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd
Treatments:
Rosuvastatin Calcium
Telmisartan